Suppr超能文献

替尔泊肽对减轻阿霉素诱导的大鼠模型氧化应激和认知缺陷无效。

Ineffectiveness of tirzepatide in mitigating Doxorubicin-induced oxidative stress and cognitive deficits in a rat model.

作者信息

Alolayan Salma A, Alhowail Ahmad H

机构信息

Department of Pharmacology and Toxicology, College of Pharmacy, Qassim, University, Buraydah, Saudi Arabia.

出版信息

Front Pharmacol. 2025 Aug 5;16:1638527. doi: 10.3389/fphar.2025.1638527. eCollection 2025.

Abstract

Doxorubicin (DXN) is widely utilized for the treatment of various cancer types. However, prolonged DXN administration induces vascular impairment and neurological effects, including cognitive deficits. Here, we investigated the efficacy of tirzepatide (TIR), an antidiabetic agent that improve cognitive function in diabetic rats, in alleviating cognitive impairment in DXN-treated rats. Forty female Wistar rats were allocated to four experimental groups: Control, DXN (5 mg/kg body weight (BW)), TIR (1.35 mg/kg BW), and DXN + TIR (5 mg DXN/kg BW followed by 1.35 mg TIR/kg BW). The compounds were injected intraperitoneally over four cycles. Mortality rates, alterations in body weight (BW), behavior, and oxidative stress markers were evaluated. The mortality rates in the control and TIR groups remained 0%, whereas those in the DXN and DXN + TIR groups were 30% and 40%, respectively. A decline in body weight was detected in rats treated with DXN and DXN + TIR, significantly relative to those in the control and TIR groups. Behavioral assessments revealed that subjects administered with DXN showed impairments, as evidenced by their performance in the Y-maze, MORT, and EPMT tasks. Furthermore, the addition of TIR did not alleviate these impairments. Superoxide dismutase (SOD) and glutathione peroxidase (GPx) levels were diminished in the DXN and DXN + TIR groups although not changes in catalase, whereas reactive oxygen species (ROS), lipid peroxidation, and malondialdehyde (MDA) levels were increased relative to those in the control group. Additionally, the functionality of mitochondrial complex-I was found to be compromised in DXN and DXN + TIR in comparison to the control group. In conclusion, the findings demonstrate that DXN induces neurotoxicity and cognitive impairments through the mechanism of increased oxidative stress. Furthermore, the concurrent administration of TIR did not mitigate the neurotoxic effects, as evidenced by persistent oxidative stress and cognitive deficits.

摘要

多柔比星(DXN)被广泛用于治疗各种癌症类型。然而,长期使用DXN会导致血管损伤和神经效应,包括认知缺陷。在此,我们研究了替尔泊肽(TIR)(一种可改善糖尿病大鼠认知功能的抗糖尿病药物)对减轻DXN处理大鼠认知障碍的疗效。将40只雌性Wistar大鼠分为四个实验组:对照组、DXN组(5毫克/千克体重(BW))、TIR组(1.35毫克/千克BW)和DXN + TIR组(先给予5毫克DXN/千克BW,随后给予1.35毫克TIR/千克BW)。这些化合物在四个周期内进行腹腔注射。评估死亡率、体重(BW)变化、行为和氧化应激标志物。对照组和TIR组的死亡率均为0%,而DXN组和DXN + TIR组的死亡率分别为30%和40%。与对照组和TIR组相比,DXN和DXN + TIR处理的大鼠体重下降。行为评估显示,给予DXN的大鼠表现出损伤,这在它们在Y迷宫、MORT和EPMT任务中的表现中得到证明。此外,添加TIR并没有减轻这些损伤。DXN组和DXN + TIR组中的超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GPx)水平降低,而过氧化氢酶无变化,而活性氧(ROS)、脂质过氧化和丙二醛(MDA)水平相对于对照组增加。此外,与对照组相比,发现DXN和DXN + TIR组中的线粒体复合物I功能受损。总之,研究结果表明,DXN通过增加氧化应激机制诱导神经毒性和认知障碍。此外,同时给予TIR并没有减轻神经毒性作用,持续的氧化应激和认知缺陷证明了这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b6f/12392119/4c354c4b329c/fphar-16-1638527-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验